In pharmacological interventions, the same variant of NMDAR (GRIN2B) has been proposed to act as a genetic predictor of treatment-resistant depression (TRD) in patients with major depressive disorder (MDD) [32]. The gene discussed is GRIN2B; the disease is major depressive disorder.